BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen T, Lin J, Wang W, Fleming J, Chen L, Wang Y, Li H, Guo H, Zhou J, Chen X, Chen Y, Liao Q, Shu Y, Tan Y, Yu M, Li G, Zhou L, Zhong Q, Bi L, Guo L, Zhao M. Cytokine and Antibody Based Diagnostic Algorithms for Sputum Culture-Positive Pulmonary Tuberculosis. PLoS One 2015;10:e0144705. [PMID: 26674517 DOI: 10.1371/journal.pone.0144705] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Delemarre EM, van Hoorn L, Bossink AWJ, Drylewicz J, Joosten SA, Ottenhoff THM, Akkerman OW, Goletti D, Petruccioli E, Navarra A, van den Broek BTA, Paardekooper SPA, van Haeften I, Koenderman L, Lammers JJ, Thijsen SFT, Hofland RW, Nierkens S. Serum Biomarker Profile Including CCL1, CXCL10, VEGF, and Adenosine Deaminase Activity Distinguishes Active From Remotely Acquired Latent Tuberculosis. Front Immunol 2021;12:725447. [PMID: 34691031 DOI: 10.3389/fimmu.2021.725447] [Reference Citation Analysis]
2 Ma Z, Ji X, Yang H, He J, Zhang Q, Wang Y, Wang Z, Chen C. Screening and evaluation of Mycobacterium tuberculosis diagnostic antigens. Eur J Clin Microbiol Infect Dis 2020;39:1959-70. [PMID: 32548683 DOI: 10.1007/s10096-020-03951-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Lui G, Wong CK, Ip M, Chu YJ, Yung IM, Cheung CS, Zheng L, Lam JS, Wong KT, Sin WW, Choi KW, Lee N. HMGB1/RAGE Signaling and Pro-Inflammatory Cytokine Responses in Non-HIV Adults with Active Pulmonary Tuberculosis. PLoS One 2016;11:e0159132. [PMID: 27434276 DOI: 10.1371/journal.pone.0159132] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
4 MacLean E, Broger T, Yerlikaya S, Fernandez-Carballo BL, Pai M, Denkinger CM. A systematic review of biomarkers to detect active tuberculosis. Nat Microbiol 2019;4:748-58. [PMID: 30804546 DOI: 10.1038/s41564-019-0380-2] [Cited by in Crossref: 68] [Cited by in F6Publishing: 61] [Article Influence: 22.7] [Reference Citation Analysis]
5 Halliday A, Masonou T, Tolosa-wright M, Mandagere V, Lalvani A. Immunodiagnosis of active tuberculosis. Expert Review of Respiratory Medicine 2019;13:521-32. [DOI: 10.1080/17476348.2019.1615888] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Carrère-Kremer S, Rubbo PA, Pisoni A, Bendriss S, Marin G, Peries M, Bolloré K, Terru D, Godreuil S, Bourdin A, Van de Perre P, Tuaillon E. High IFN-γ Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis. PLoS One 2016;11:e0162137. [PMID: 27603919 DOI: 10.1371/journal.pone.0162137] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
7 Xiao JN, Xiong Y, Chen Y, Xiao YJ, Ji P, Li Y, Wang SJ, Zhao GP, Cheng QJ, Lu SH, Wang Y. Determination of Lipoprotein Z-Specific IgA in Tuberculosis and Latent Tuberculosis Infection. Front Cell Infect Microbiol 2017;7:495. [PMID: 29250493 DOI: 10.3389/fcimb.2017.00495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Wykowski JH, Phillips C, Ngo T, Drain PK. A systematic review of potential screening biomarkers for active TB disease. J Clin Tuberc Other Mycobact Dis 2021;25:100284. [PMID: 34805557 DOI: 10.1016/j.jctube.2021.100284] [Reference Citation Analysis]